drugset / Trial / NCT05269329

Efficacy and Safety of XC8, Film-coated Tablets, 10 mg in Patients With Dry Non-productive Cough Against Acute Respiratory Viral Infection

NCT05269329 ↗

Phase 2 Completed 160 enrolled Valenta Pharm JSC
RandomizedParallel-groupDouble-blindTreatment

Summary

Study to assess the efficacy and safety of XC8, film-coated tablets, 10 mg in comparison with placebo in patients with dry non-productive cough against acute respiratory infections, and to determine the dosing regimen of XC8, film-coated tablets, 10 mg for treatment of dry non-productive cough against acute respiratory infections.

Timeline

Start
2021-04-26
Primary completion
2021-10-26
Completion
2021-10-26

Drugs

EvaluationDrugModalityDoseRoute
Subject XC8 Unknown 20 mg —
Subject XC8 Unknown 40 mg —
Subject XC8 Unknown 80 mg —

Indications